Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Susan Calcaterra to United States

This is a "connection" page, showing publications Susan Calcaterra has written about United States.

 
Connection Strength
 
 
 
0.507
 
  1. Calcaterra SL, Yamkovoy K, Swathi PA, Ciccarone D, Del Pozo B, Englander H, Wang J, Barocas JA. U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019. Drug Alcohol Depend. 2024 Sep 01; 262:111409.
    View in: PubMed
    Score: 0.069
  2. Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 07 25; 21(1):140.
    View in: PubMed
    Score: 0.069
  3. Calcaterra SL, Dafoe A, Tietbohl C, Thurman L, Bredenberg E. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients. J Hosp Med. 2024 Jun; 19(6):460-467.
    View in: PubMed
    Score: 0.067
  4. Calcaterra SL, Peterkin AF. Antiracist Strategies to Combat Racial Disparities in the Delivery of Hospital-Based Addiction Care. J Gen Intern Med. 2024 Feb; 39(2):165-167.
    View in: PubMed
    Score: 0.067
  5. Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2022; 43(1):143-151.
    View in: PubMed
    Score: 0.051
  6. Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019 06; 34(6):1039-1042.
    View in: PubMed
    Score: 0.047
  7. Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, Dart RC. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clin Toxicol (Phila). 2018 11; 56(11):1107-1114.
    View in: PubMed
    Score: 0.044
  8. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70.
    View in: PubMed
    Score: 0.031
  9. Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2):129-36.
    View in: PubMed
    Score: 0.031
  10. Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Med. 2018 11 01; 19(11):2201-2211.
    View in: PubMed
    Score: 0.012
  11. Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
    View in: PubMed
    Score: 0.010
  12. Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug Alcohol Depend. 2015 Dec 01; 157:150-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)